Literature DB >> 24263025

Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant.

Victor I Peinado1, Federico P Gómez, Joan Albert Barberà, Antonio Roman, M Angels Montero, Josep Ramírez, Josep Roca, Roberto Rodriguez-Roisin.   

Abstract

BACKGROUND: Little is known about the structure and function relationships of pulmonary vessels in the most severe chronic obstructive pulmonary disease (COPD) spectrum. We investigated morphometric, cellular, and physiologic characteristics of pulmonary arteries from COPD patients undergoing bilateral lung transplant.
METHODS: Seventeen patients with very severe COPD (forced expiratory volume in 1 second, 24% ± 7%) were assessed using inert gas exchange and pulmonary hemodynamics while breathing ambient air and 100% oxygen. Morphometry, in vitro reactivity to hypoxia, and inflammatory cell counts of pulmonary arteries were measured in explanted lungs.
RESULTS: Patients had moderate ventilation-perfusion imbalance along with mild release of hypoxic pulmonary vasoconstriction. Mild pulmonary hypertension was observed in 7 patients. Explanted lungs had predominant emphysema with mild small airway involvement. In vitro reactivity was modestly altered, with relatively preserved endothelium-dependent relaxation, and vascular remodelling was discrete, with intense CD8+ T lymphocytes infiltrate. In vitro reactivity correlated with pulmonary vascular resistance (on ambient air) and oxygen-induced pulmonary artery pressure changes. Patients with pulmonary hypertension had more severe morphologic and physiologic emphysema.
CONCLUSIONS: In end-stage COPD patients undergoing lung transplant, pulmonary vascular involvement is unexpectedly modest, with low-grade endothelial dysfunction. In this sub-set of COPD patients, pulmonary emphysema may constitute the major determinant of the presence of pulmonary hypertension.
© 2013 International Society for Heart and Lung Transplantation Published by International Society for the Heart and Lung Transplantation All rights reserved.

Entities:  

Keywords:  end-stage chronic obstructive pulmonary disease; pulmonary circulation; pulmonary emphysema; pulmonary vascular reactivity; ventilation-perfusion imbalance

Mesh:

Year:  2013        PMID: 24263025     DOI: 10.1016/j.healun.2013.09.007

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  10 in total

1.  Sildenafil Prevents Marfan-Associated Emphysema and Early Pulmonary Artery Dilation in Mice.

Authors:  Zoe White; Nadia Milad; Arash Y Tehrani; Jennifer Lamothe; James C Hogg; Mitra Esfandiarei; Michael Seidman; Steven Booth; Tillie-Louise Hackett; Mathieu C Morissette; Pascal Bernatchez
Journal:  Am J Pathol       Date:  2019-05-22       Impact factor: 4.307

2.  Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD.

Authors:  Aparna Balasubramanian; Todd M Kolb; Rachel L Damico; Paul M Hassoun; Meredith C McCormack; Stephen C Mathai
Journal:  Chest       Date:  2020-03-14       Impact factor: 9.410

3.  Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.

Authors:  Karina Portillo; Yolanda Torralba; Isabel Blanco; Felip Burgos; Roberto Rodriguez-Roisin; Jose Rios; Josep Roca; Joan A Barberà
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-14

4.  Effect of azithromycin in combination with simvastatin in the treatment of chronic obstructive pulmonary disease complicated by pulmonary arterial hypertension.

Authors:  Peidong Wang; Jie Yang; Yanwei Yang; Zhixin Ding
Journal:  Pak J Med Sci       Date:  2017 Mar-Apr       Impact factor: 1.088

5.  Pulmonary hyperinflation due to gas trapping and pulmonary artery size: The MESA COPD Study.

Authors:  Hooman D Poor; Steven M Kawut; Chia-Ying Liu; Benjamin M Smith; Eric A Hoffman; João A Lima; Bharath Ambale-Venkatesh; Erin D Michos; Martin R Prince; R Graham Barr
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

Review 6.  Updated Perspectives on Pulmonary Hypertension in COPD.

Authors:  Isabel Blanco; Olga Tura-Ceide; Victor Ivo Peinado; Joan Albert Barberà
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-09

7.  Differential coexpression networks in bronchiolitis and emphysema phenotypes reveal heterogeneous mechanisms of chronic obstructive pulmonary disease.

Authors:  Jiangyue Qin; Ting Yang; Ni Zeng; Chun Wan; Lijuan Gao; Xiaoou Li; Lei Chen; Yongchun Shen; Fuqiang Wen
Journal:  J Cell Mol Med       Date:  2019-08-16       Impact factor: 5.310

Review 8.  Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide.

Authors:  Agustín Roberto García; Lucilla Piccari
Journal:  Curr Opin Pulm Med       Date:  2022-07-16       Impact factor: 2.868

9.  Pulmonary arterial enlargement predicts long-term survival in COPD patients.

Authors:  Juan P de-Torres; Ana Ezponda; Ana B Alcaide; Arantza Campo; Juan Berto; Jessica Gonzalez; Javier J Zulueta; Ciro Casanova; Luisa Elena Rodriguez-Delgado; Bartolome R Celli; Gorka Bastarrika
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

10.  Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study.

Authors:  Shingo Nakayama; Shotaro Chubachi; Kaori Sakurai; Hidehiro Irie; Akihiro Tsutsumi; Mizuha Hashiguchi; Yuji Itabashi; Mitsushige Murata; Hidetoshi Nakamura; Koichiro Asano; Koichi Fukunaga
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.